<DOC>
	<DOC>NCT01400971</DOC>
	<brief_summary>The purpose of this study is to identify specific patient, physician, and health system related factors associated with the progression to a more intensive regimen from initial insulin therapy for patients with type 2 diabetes.</brief_summary>
	<brief_title>An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Have been diagnosed with type 2 diabetes Have presented within the normal course of care Have been on their initial insulin therapy for â‰¥3 months (with or without any combination of approved noninsulin antidiabetic medications) Are not simultaneously participating in a study that includes an investigational drug or procedure at entry into the study Have been fully informed and have given written consent for the use of their data Have a sufficient understanding of the primary language of the country such that they will be able to complete the questionnaires Have not initiated basal bolus therapy (three mealtime insulin injections)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Insulin</keyword>
	<keyword>Progression</keyword>
	<keyword>Patient Reported Measures</keyword>
	<keyword>Adherence</keyword>
	<keyword>Heterogeneity</keyword>
	<keyword>Hypoglycemia</keyword>
</DOC>